Cultural

Thailand BOI Says 2024 Investment Applications Soar 35% to 10-Year High of USD33 Billion as FDI in Data Centers and Cloud Services Take the Lead

BANGKOK,Jan. 13,2025-- The Thailand Board of Investment (BOI) said today that applications for investment promotion in 2024 soared 35% in value to 1.14 trillion baht (ca. USD 33 billion),the highest l

01-14

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

MELBOURNE,Australiaand INDIANAPOLIS,Jan. 13,2025-- Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today provides an update on its commercial and operational performance for th

01-14

CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI,Jan. 13,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

01-14

Olight Donating Emergency Flashlights in Response to Los Angeles Wildfires

LOS ANGELES,Jan. 14,2025-- Olight,the global leader in portable lighting solutions,donated 1,336 flashlights,valued at $56,830,in response to the devastating wildfires that swept through Los Angeles.

01-14

Huawei Unveils a New Era of Foldable Excellence at 'Unfold the Classic' Launch in Dubai

DUBAI,UAE,Jan. 13,2025-- Huawei Consumer Business Group unveiled several highly anticipated products that ushers in a new era of flagship foldable excellence,as part of the "Unfold the Classic&qu

01-14

CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI,Jan. 13,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

01-14

ROMOSS Showcases Latest Charging Innovations at CES 2025, Paving the Way for Global Market Expansion

LAS VEGAS,Jan. 14,2025-- AtCES 2025,held from January 7-10 in Las Vegas,ROMOSS captivated global audiences with its latest charging technology and products,underscoring its commitment to an all-scenar

01-14

GlobalTix Named VinWonders' Growth Partner of the Year 2024

HO CHI MINH CITY,Vietnam,Jan. 14,2025-- GlobalTix,Asia\'s leading ticketing and marketplace distribution platform,has been named "Growth Partner of the Year" by VinWonders,Vietnam\'s premie

01-14

Corn Next Launches CornNext-17: A Groundbreaking Sustainable Solution to Plastic Pollution

IRVINE,Calif.,Jan. 11,2025-- Corn Next,a leader in sustainable innovation and biodegradable solutions,has officially launched CornNext-17,a game-changing bio-based material designed to combat the glob

01-13

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform,similar to the preclinical stage KAT6 inhibitor (MEN2312) licen

01-13

Home Previous 49 50 51 52 53 54 55 Next Tail

10 Items Per Page (Page 52 / 102) Total 1020 Items

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map